AI assistant
Flerie AB — Net Asset Value 2026
May 5, 2026
6601_rns_2026-05-05_3b976720-6f4d-4ad6-b898-6ff73487b723.pdf
Net Asset Value
Open in viewerOpens in your device viewer
Press Release 05 May 2026 08:00:00 CEST
==> picture [98 x 44] intentionally omitted <==
NET ASSET VALUE – 30 April 2026
On the 30 April 2026 Flerie AB's Net Asset Value (NAV) was SEK 3,478 million and NAV per share was SEK 41.79. Return on NAV per share in the month was -0.26%.
==> picture [455 x 459] intentionally omitted <==
----- Start of picture text ----- Allocation of NAV Share of portfolio company Fair value (MSEK) Part of NAV per share (SEK) Share of NAVProduct DevelopmentLipum 100% 348 4.18 10.0%Prokarium 50% 280 3.36 8.0%Xspray Pharma 17% 217 2.60 6.2%Empros Pharma 79% 204 2.46 5.9%KAHR Medical 34% 199 2.39 5.7%Atrogi 44% 197 2.37 5.7%Bonsai Biotherapeutics 100% 158 1.90 4.5%Microbiotica 10% 125 1.51 3.6%Xintela 60% 122 1.47 3.5%AnaCardio 13% 79 0.95 2.3%Mendus 23% 69 0.82 2.0%Geneos Therapeutics 12% 66 0.80 1.9%EpiEndo Pharmaceuticals 9% 54 0.65 1.5%Vitara Biomedical 11% 52 0.63 1.5%Buzzard Pharmaceuticals 15% 33 0.40 1.0%Egetis Therapeutics 1% 27 0.33 0.8%Amarna Therapeutics 58% 11 0.13 0.3%Strike Pharma 18% 11 0.13 0.3%Total 2,253 27.07 64.8%Commercial GrowthSymcel 30% 204 2.46 5.9%NorthX Biologics 61% 202 2.43 5.8%Chromafora 28% 137 1.65 4.0%Nanologica 50% 86 1.03 2.5%Frontier Biosolutions 2% 26 0.31 0.8%Bohus Biotech 45% 0 0.00 0.0%Total 656 7.88 18.9%Assets related to Portfolio companies 204 2.45 5.9%Other assets and liabilities 365 4.39 10.5%Net Asset Value 3,478 41.79 100.0%----- End of picture text -----
For more information:
Ted Fjällman, CEO Email: [email protected]
Flerie AB Skeppsbron 16 111 30 Stockholm
Press Release 05 May 2026 08:00:00 CEST
==> picture [98 x 44] intentionally omitted <==
Flerie in brief
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com
Attachments
NET ASSET VALUE – 30 April 2026
Flerie AB Skeppsbron 16 111 30 Stockholm